Main Capital Partners Makes Majority Investment in LuxSci
November 3, 2023
Main Capital Partners has made a majority investment in Lux Scientiae, Incorporated (LuxSci), a U.S.-based provider of HIPAA-compliant secure communications and hosting solutions for healthcare and other regulated industries. The partnership will provide LuxSci with resources to accelerate product development, pursue strategic acquisitions, and expand internationally while Main leverages its healthcare and security software experience to support growth.
- Buyers
- Main Capital Partners
- Targets
- Lux Scientiae, Incorporated (LuxSci)
- Industry
- Software
- Location
- Massachusetts, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Main Capital Partners Acquires Majority Stake in PRIM'X
June 24, 2025
Cybersecurity
Main Capital Partners has made a majority investment in French encryption and data confidentiality software provider PRIM'X, with PRIM'X management retaining a significant minority stake. The partnership will support PRIM'X's international expansion, product-suite development and buy-and-build strategy to deepen its presence across defense, government and other mission-critical markets.
-
LIAN Group Acquires Scientis to Expand Healthcare Platform
August 28, 2024
Healthcare Services
LIAN Group, an owner-operator investment firm, has acquired Scientis, a Swiss dermatology and cosmeceutical company known for its Cyspera pigment-correcting product line. The deal expands LIAN's Healthcare investment platform and aims to accelerate Scientis’ global growth, product development and market penetration across Asia, the United States and other markets.
-
LIAN Group Acquires Scientis to Expand Healthcare Platform
August 28, 2024
Healthcare Services
LIAN Group, through its Healthcare investment platform, has acquired Scientis, a Swiss cosmeceutical company known for its Cyspera pigment-correcting product line. The deal is intended to accelerate Scientis' global growth, expand LIAN's footprint into beauty and wellbeing, and support product and market development using LIAN's owner-operator capabilities.
-
GHO Capital Partners Acquires Majority Stake in Sapio Sciences
December 1, 2022
Cloud & SaaS
London-based healthcare investor GHO Capital Partners has acquired a majority stake in Sapio Sciences, a US-based lab informatics platform providing LIMS, ELN and scientific data management solutions. GHO will support Sapio's international expansion (especially into Europe), operational improvements and growth through M&A to scale the company's SaaS offering for biopharma, CROs and diagnostic labs.
-
LIAN Group Acquires Scientis
August 28, 2024
Healthcare Services
LIAN Group, an owner-operator investment firm, has acquired Swiss cosmeceuticals company Scientis, maker of the dermatology product Cyspera. The acquisition strengthens LIAN's healthcare platform and aims to accelerate Scientis's commercial expansion into global markets including Asia and the United States.
-
Summit Partners Makes Majority Growth Investment in LumaBridge
August 23, 2022
Healthcare Services
Summit Partners has made a majority growth equity investment in LumaBridge, an oncology-focused clinical research organization (CRO) headquartered in San Antonio, Texas. The capital will support LumaBridge’s expansion of clinical trial capabilities and enable the company to serve a larger number of emerging biopharma sponsors developing immuno-oncology therapies.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.